Optimal design for a study of butadiene toxicokinetics in humans

被引:30
作者
Bois, FY
Smith, TJ
Gelman, A
Chang, HY
Smith, AE
机构
[1] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA
[2] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[3] Columbia Univ, Dept Stat, New York, NY USA
关键词
butadiene population toxicokinetics; human inhalation experiments; Markov chain Monte Carlo simulations; optimal experimental design;
D O I
10.1093/toxsci/49.2.213
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The derivation of the optimal design for an upcoming toxicokinetic study of butadiene in humans is presented. The specific goal of the planned study is to obtain a precise estimate of butadiene metabolic clearance for each study subject, together with a good characterization of its population variance. We used a two-compartment toxicokinetic model, imbedded in a hierarchical population model of variability, in conjunction with a preliminary set of butadiene kinetic data in humans, as a basis for design optimization. Optimization was performed using Monte Carlo simulations. Candidate designs differed in the number and timing of exhaled air samples to be collected. Simulations indicated that only 10 air samples should be necessary to obtain a coefficient of variation of 15% for the estimated clearance rate, if the timing of those samples is properly chosen. Optimal sampling times were found to closely bracket the end of exposure. This efficient design will allow the recruitment of more subjects in the study, in particular to match prescribed levels of accuracy in the estimate of the population variance of the butadiene metabolic rate constant, The techniques presented here have general applicability to the design of human and animal toxicology studies.
引用
收藏
页码:213 / 224
页数:12
相关论文
共 51 条
  • [1] OPTIMUM EXPERIMENTAL-DESIGNS FOR PROPERTIES OF A COMPARTMENTAL MODEL
    ATKINSON, AC
    CHALONER, K
    HERZBERG, AM
    JURITZ, J
    [J]. BIOMETRICS, 1993, 49 (02) : 325 - 337
  • [2] Atkinson AC., 1992, OPTIMUM EXPT DESIGN
  • [3] Beatty D A, 1997, Stat Methods Med Res, V6, P359
  • [4] Bernardo J.M., 2009, Bayesian Theory, V405
  • [5] Bois F.Y., 1997, J STAT SOFTWARE, V2
  • [6] Population toxicokinetics of benzene
    Bois, FY
    Jackson, ET
    Pekari, K
    Smith, MT
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1996, 104 : 1405 - 1411
  • [7] Population toxicokinetics of tetrachloroethylene
    Bois, FY
    Gelman, A
    Jiang, J
    Maszle, DR
    Zeise, L
    Alexeef, G
    [J]. ARCHIVES OF TOXICOLOGY, 1996, 70 (06) : 347 - 355
  • [8] The use of toxicologic data in mechanistic risk assessment: 1,3-butadiene as a case study
    Bond, JA
    Himmelstein, MW
    Medinsky, MA
    [J]. INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, 1996, 68 (06) : 415 - 420
  • [9] ANALYSIS OF 1,3-BUTADIENE AND OTHER SELECTED GAS-PHASE COMPONENTS IN CIGARETTE MAINSTREAM AND SIDESTREAM SMOKE BY GAS-CHROMATOGRAPHY MASS SELECTIVE DETECTION
    BRUNNEMANN, KD
    KAGAN, MR
    COX, JE
    HOFFMANN, D
    [J]. CARCINOGENESIS, 1990, 11 (10) : 1863 - 1868
  • [10] Evaluation of a sparse sampling strategy for determining vancomycin pharmacokinetics in preterm neonates: Application of optimal sampling theory
    Burstein, AH
    Gal, P
    Forrest, A
    [J]. ANNALS OF PHARMACOTHERAPY, 1997, 31 (09) : 980 - 983